While the binding properties of tau in AD brains are not yet completely understood, nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) competitive modeling studies [44] showed some correlation between tubulin binding in the TauF4 and T2R (tau fragments) and vinblastine and colchicine binding sites. The gene discussed is MAPT; the disease is Alzheimer disease.